New Sanofi ($SNY) CEO Olivier Brandicourt is assembling his top team. The pharma giant announced that Novartis ($NVS) vet Ameet Nathwani has been named EVP and group chief medical officer, earning a seat on the executive committee. Nathwani is taking the place of Paul Chew, who's retiring later in the year. Sanofi has been setting the stage for a reorganization. Release
@FierceBiotech: Strike 3: Struggling Xoma jettisons its lead drug after (another) PhIII failure. News | Follow @FierceBiotech
@JohnCFierce: Sarepta has a new date with an FDA AdCom for Duchenne drug eteplirsen. Article | Follow @JohnCFierce
> Epizyme ($EPZM) CEO Robert Bazemore mapped out a 5-year plan for the company, including the development of tazemetostat. Release
> CRISPR Therapeutics has named Marc Becker as its new CFO. He had been the CFO at rEVO Biologics. Release
> Germany's Evotec achieved a preclinical milestone for the work it's doing for Padlock Therapeutics. Release
Medical Device News
@FierceMedDev: BD forms $500M JV with private equity firm Apax to house ailing respiratory biz. More | Follow @FierceMedDev
@VarunSaxena2: FDA loss in Vascular Solution off-label promotion case foreshadowed Amarin settlement. Story | Follow @VarunSaxena2
@EmilyWFierce: Biopharma, Republicans and doctors dig in for fight against new CMS cancer-drug cuts. Article | Follow @EmilyWFierce
> Theranos rival HealthTell raises $26M to support its drop-of-blood diagnostics. More
> Abbott to launch 1,000+ patient trial to standardize traumatic brain injury testing. Story
Pharma News
@FiercePharma: Ceva makes strides toward animal health dominance with strong 2015 sales. More | Follow @FiercePharma
@EricPFierce: More biologics manufacturing capacity comes online in the US. Story | Follow @EricPFierce
@CarlyHFierce: AbbVie's $595M anti-inflammatory deal promises an even bigger battle for psoriasis share. News | Follow @CarlyHFierce
> In a welcome, surprising reversal, pharma's reputation among patients takes an upturn. Story
> Valeant settles the R&O lawsuit that touched off its specialty pharmacy woes. Report
CRO News
> 'Molecule to blame' in fatal French drug study. More
> Icon teams up with a nonprofit to help drive better patient outcomes. Report
> Data collection firm ERT is changing private equity hands. Story
> Swiss CRO PSI stretches its reach into Israel. Article
Pharma Manufacturing News
> Merck hands top manufacturing job to Sanat Chattopadhyay. Report
> Lupin finishes Gavis buy, giving it U.S. manufacturing beachhead. Story
> Bain-backed compounder QuVa gets slapped by FDA for plant failings. Article
> Pfizer expanding API plant in Australia. Item
Pharma Asia News
> Price pressure on drug sales in China accelerates in 2016. Report
> Japan's AMED names 8 projects for pre-designation orphan review. Item
> Carlyle-backed Meinian Onehealth snaps up Ciming for $415M. Story
> China FDA approves Roche's cervical test CINtec. More
> Challenged Benitec moves to get word out on hep B candidate. Article